Incidence, Risk Factors, Treatment, and Outcome of Ocular Hypertension following Intravitreal Steroid Injections: A Comparative Study
Conclusion: Twenty-eight percent of TA and 17% of Dex administrations developed OHT. Early and severe IOP rises were more common in TA than among Dex administrations. Myopia is a risk for Dex-OHT.Ophthalmologica
Source: Ophthalmologica - Category: Opthalmology Source Type: research
More News: Dexamethasone | Diabetes | Diabetes Mellitus | Endocrinology | Eye Implants | Eyes | Glaucoma | Hypertension | Myopia (short sighted) | Opthalmology | Statistics | Study | Triamcinolone